Screener
AngioDynamics ANGO Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | May 31, 2026 | May 31, 2025 |
|---|---|---|
| Total current assets | 163,394 | 168,324 |
| Property, plant and equipment, net | 27,097 | 32,300 |
| Intangible assets, net | 67,209 | 69,116 |
| Other assets | 9,463 | 10,404 |
| Total Assets | $267,163 | $280,144 |
| Liabilities and Stockholders' Equity | ||
| Current Liabilities | ||
| Accounts payable | $31,513 | $33,291 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's deferred tax assets and other non-current assets?
- AngioDynamics (ANGO) reported deferred tax assets and other non-current assets of $9.46M in Q1 2026.
- How has AngioDynamics's deferred tax assets and other non-current assets changed year-over-year?
- AngioDynamics's deferred tax assets and other non-current assets decreased by 9.0% year-over-year, from $10.4M to $9.46M.
- What is the long-term trend for AngioDynamics's deferred tax assets and other non-current assets?
- Over 5 years (2021 to 2026), AngioDynamics's deferred tax assets and other non-current assets has grown at a -6.4% compound annual growth rate (CAGR), from $13.19M to $9.46M.
Ask your AI about AngioDynamics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude